Select Medical Holdings Reports Financial Condition and Operations
Ticker: SEM · Form: 8-K · Filed: Feb 22, 2024 · CIK: 1320414
Sentiment: neutral
Topics: financial-condition, operations, 8-K
TL;DR
**Select Medical Holdings just dropped an 8-K on its financials, so keep an eye out for the details!**
AI Summary
SELECT MEDICAL HOLDINGS CORPORATION filed an 8-K on February 22, 2024, reporting on its results of operations and financial condition. The filing indicates the company's business address is 4714 Gettysburg Road, Mechanicsburg, PA 17055, and its telephone number is 717-972-1100. This 8-K primarily serves to disclose financial information and other events as required by the Securities Exchange Act of 1934.
Why It Matters
This filing provides investors with current information on Select Medical Holdings' financial health and operational performance, crucial for making informed investment decisions.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial results and operations, not indicating any immediate new risks.
Key Players & Entities
- SELECT MEDICAL HOLDINGS CORPORATION (company) — Registrant
- February 22, 2024 (date) — Date of earliest event reported
- 4714 Gettysburg Road, P.O. Box 2034 Mechanicsburg, PA 17055 (address) — Principal executive offices
- 717-972-1100 (phone_number) — Registrant's telephone number
- 001-34465 (other) — Commission File Number
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant as specified in its charter is SELECT MEDICAL HOLDINGS CORPORATION.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is February 22, 2024.
What is the business address of SELECT MEDICAL HOLDINGS CORPORATION?
The business address of SELECT MEDICAL HOLDINGS CORPORATION is 4714 Gettysburg Road, P.O. Box 2034 Mechanicsburg, PA 17055.
What is the telephone number for SELECT MEDICAL HOLDINGS CORPORATION?
The telephone number for SELECT MEDICAL HOLDINGS CORPORATION is 717-972-1100.
What items are reported in this 8-K filing?
This 8-K filing reports on Results of Operations and Financial Condition, Other Events, and Financial Statements and Exhibits.
Filing Stats: 582 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-02-22 16:43:32
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share SEM New York Stock Exchange
- $0.125 — , the Board declared a cash dividend of $0.125 per share. The dividend will be payable
Filing Documents
- tm246929d1_8k.htm (8-K) — 28KB
- tm246929d1_ex99-1.htm (EX-99.1) — 303KB
- tm246929d1_ex99-1img001.jpg (GRAPHIC) — 13KB
- 0001104659-24-026568.txt ( ) — 545KB
- sem-20240222.xsd (EX-101.SCH) — 3KB
- sem-20240222_lab.xml (EX-101.LAB) — 33KB
- sem-20240222_pre.xml (EX-101.PRE) — 22KB
- tm246929d1_8k_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On February 22, 2024, Select Medical Holdings Corporation (the " Company ") issued a press release announcing its financial results for its fourth quarter and fiscal year ended December 31, 2023 (the " Press Release "). A copy of the Press Release and the attached financial schedules are attached as Exhibit 99.1 to this report and incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act "), or the Exchange Act.
01 Other Events
Item 8.01 Other Events Dividend Declaration On February 13, 2024, the Board declared a cash dividend of $0.125 per share. The dividend will be payable on or about March 13, 2024 to stockholders of record as of the close of business on March 1, 2024.
01 Financial
Item 9.01 Financial (d) Exhibits. Exhibit Number Description 99.1 Press Release, dated February 22, 2024, announcing financial results for the fourth quarter and year ended December 31, 2023. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned, thereunto duly authorized. SELECT MEDICAL HOLDINGS CORPORATION Date: February 22, 2024 By: /s/ Michael E. Tarvin Michael E. Tarvin Executive Vice President, General Counsel and Secretary